BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 30101452)

  • 1. Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.
    Gamet A; Degand B; Le Gal F; Bidegain N; Delaubier A; Gilbert-Dussardier B; Christiaens L; Garcia R
    Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12587. PubMed ID: 30101452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study.
    Dello Russo A; Mangiola F; Della Bella P; Nigro G; Melacini P; Bongiorni MG; Tondo C; Calò L; Messano L; Pace M; Pelargonio G; Casella M; Sanna T; Silvestri G; Modoni A; Zachara E; Moltrasio M; Morandi L; Nigro G; Politano L; Palladino A; Bellocci F
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):51-8. PubMed ID: 19708226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.
    Groh WJ; Groh MR; Saha C; Kincaid JC; Simmons Z; Ciafaloni E; Pourmand R; Otten RF; Bhakta D; Nair GV; Marashdeh MM; Zipes DP; Pascuzzi RM
    N Engl J Med; 2008 Jun; 358(25):2688-97. PubMed ID: 18565861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.
    Chong-Nguyen C; Wahbi K; Algalarrondo V; Bécane HM; Radvanyi-Hoffman H; Arnaud P; Furling D; Lazarus A; Bassez G; Béhin A; Fayssoil A; Laforêt P; Stojkovic T; Eymard B; Duboc D
    Circ Cardiovasc Genet; 2017 Jun; 10(3):. PubMed ID: 28611030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II.
    Ha AH; Tarnopolsky MA; Bergstra TG; Nair GM; Al-Qubbany A; Healey JS
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1262-9. PubMed ID: 22385162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation.
    Russo V; Papa AA; Rago A; Ciardiello C; Martino AM; Stazi A; Golino P; Calò L; Nigro G
    Europace; 2022 Jul; 24(7):1148-1155. PubMed ID: 35861549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.
    Breton R; Mathieu J
    Can J Cardiol; 2009 Feb; 25(2):e23-7. PubMed ID: 19214296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myotonic dystrophy type 1 and high ventricular vulnerability at the electrophysiological evaluation: ICD yes or not?
    Sirico G; Montisci A; Secchi F; Mantica M
    Acta Myol; 2020 Mar; 39(1):32-35. PubMed ID: 32607478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of Prognostic Value of T-Wave Alternans for Implantable Cardioverter-Defibrillator Benefit in Primary Prevention.
    Pelli A; Kenttä TV; Junttila MJ; Huber C; Schlögl S; Zabel M; Malik M; Willems R; Vos MA; Harden M; Friede T; Sticherling C; Huikuri HV;
    J Am Heart Assoc; 2024 Jun; 13(11):e032465. PubMed ID: 38804218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term arrhythmia follow-up of patients with myotonic dystrophy.
    Benhayon D; Lugo R; Patel R; Carballeira L; Elman L; Cooper JM
    J Cardiovasc Electrophysiol; 2015 Mar; 26(3):305-10. PubMed ID: 25546341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up.
    Vio R; Zorzi A; Bello L; Bozzoni V; Botta A; Rivezzi F; Leoni L; Migliore F; Bertaglia E; Iliceto S; Pegoraro E; Corrado D; Calore C
    Heart Rhythm; 2020 Nov; 17(11):1944-1950. PubMed ID: 32525073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease.
    Wahbi K; Meune C; Porcher R; Bécane HM; Lazarus A; Laforêt P; Stojkovic T; Béhin A; Radvanyi-Hoffmann H; Eymard B; Duboc D
    JAMA; 2012 Mar; 307(12):1292-301. PubMed ID: 22453570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?
    Clarke NR; Kelion AD; Nixon J; Hilton-Jones D; Forfar JC
    Heart; 2001 Oct; 86(4):411-6. PubMed ID: 11559681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of QRS-T angle and heart rate variability with major cardiac events and mortality in hemodialysis patients.
    Poulikakos D; Hnatkova K; Banerjee D; Malik M
    Ann Noninvasive Electrocardiol; 2018 Nov; 23(6):e12570. PubMed ID: 29938866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1.
    Joosten IBT; Janssen CEW; Horlings CGC; den Uijl D; Evertz R; van Engelen BGM; Faber CG; Vernooy K
    Europace; 2023 Feb; 25(1):156-163. PubMed ID: 35851806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1.
    Wahbi K; Babuty D; Probst V; Wissocque L; Labombarda F; Porcher R; Bécane HM; Lazarus A; Béhin A; Laforêt P; Stojkovic T; Clementy N; Dussauge AP; Gourraud JB; Pereon Y; Lacour A; Chapon F; Milliez P; Klug D; Eymard B; Duboc D
    Eur Heart J; 2017 Mar; 38(10):751-758. PubMed ID: 27941019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular manifestations of myotonic dystrophy.
    Wahbi K; Furling D
    Trends Cardiovasc Med; 2020 May; 30(4):232-238. PubMed ID: 31213350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.
    Wahbi K; Algalarrondo V; Bécane HM; Fressart V; Beldjord C; Azibi K; Lazarus A; Berber N; Radvanyi-Hoffman H; Stojkovic T; Béhin A; Laforêt P; Eymard B; Hatem S; Duboc D
    Arch Cardiovasc Dis; 2013 Dec; 106(12):635-43. PubMed ID: 24140416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
    Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of Holter monitoring in congestive heart failure.
    Cygankiewicz I; Zareba W; de Luna AB
    Cardiol J; 2008; 15(4):313-23. PubMed ID: 18698539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.